Apologies for the highlighted text,
onCARlytics represents a paradigm shift in solid tumor treatment, it is our jewel in the crown
It has the potential to target and eradicate solid tumors that otherwise cannot be treated with approved CAR-T therapies alone.
onCARlytics is safe and has shown promise both in preclinical studies and early clinical trials, offering a novel approach for solid tumor therapy.
If successful, onCARlytics could open up 90% of the cancer market and allow CD19 therapies to become an option to treat patients with solid tumours (valued at USD$500B).
More importantly we are only six months away from learning early results from the OASIS combination trial with Amgen's Blincyto ... you just got to love the science and the unbelievable value proposition it represents
GLTAH - Go Team Imugene
.
Apologies for the highlighted text, onCARlytics represents a...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
-0.001(1.72%) |
Mkt cap ! $417.2M | |||
| Open | High | Low | Value | Volume |
| 5.8¢ | 5.9¢ | 5.6¢ | $626.0K | 10.93M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 305518 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 646471 | 5 |
View Market Depth
| Last trade - 16.10pm 12/06/2024 (20 minute delay) ? |
|
|||||
|
Last
5.8¢ |
Change
-0.001 ( 0.86 %) |
||||
| Open | High | Low | Volume | ||
| 5.8¢ | 5.9¢ | 5.6¢ | 3295507 | ||
| Last updated 15.59pm 12/06/2024 ? | |||||
| IMU (ASX) Chart |